← Leaderboards
Jaehyup Kim
Ut Southwestern Medical Center
$656,870
Attributed
$656,870
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $131.4K · FY2019–23$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$656,870 · 1
By mechanism
K08$656,870 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Chengcheng Zhang$6,781,238
- Shayna Thomas-Jardin$226,480
- David Hsieh$270,981
Others in their field
Other Emerging Leaders on “Databases”
- Leonard Freedman · Leidos Biomedical Research, Inc.$186,439,178
- Klaus Romero · Critical Path Institute$90,404,592
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$68,745,882
- Leonard Freedmand · Leidos Biomedical Research, Inc.$50,302,300
- Lynn Briscoe · Leidos Biomedical Research, Inc.$50,165,970
Research focus
DatabasesExhibitsAcute Myelocytic LeukemiaAcute Myeloid Leukemia CellAdultEventAdult LeukemiaArginaseAlcam GeneBehaviorBiologyAnimal ModelAntibodiesDevelopment PlansBurden Of IllnessApolipoprotein ECareer DevelopmentCcl3 GeneCell LineageCell MotilityCell Surface ReceptorsCell SurvivalCtla4 GeneExpectation
Grant awards (5)
The role of LILRB4 in AML progression and immune suppression$131,374
K08 · FY2023 · CA · contact PI
The role of LILRB4 in AML progression and immune suppression$131,374
K08 · FY2022 · CA · contact PI
The role of LILRB4 in AML progression and immune suppression$131,374
K08 · FY2021 · CA · contact PI
The role of LILRB4 in AML progression and immune suppression$131,374
K08 · FY2020 · CA · contact PI
The role of LILRB4 in AML progression and immune suppression$131,374
K08 · FY2019 · CA · contact PI